Water-soluble pristine fullerenes C60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane

Journal of Biomedical Nanotechnology

Volumn 8, Issue 3, 2012, Pages 522-527

  Prylutska, S ^a   Bilyy, R ^b   Overchuk, M ^b   Bychko, A ^a   Andreichenko, K ^a   Stoika, R ^b   Rybalchenko, V ^a   Prylutskyy, Yu ^a   Tsierkezos, N G ^c   Ritter, U ^c  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b INSTITUTE OF CELL BIOLOGY   (Ukraine)

^c ILMENAU UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cellular plasma membrane; Conductivity; Fullerenes; Lipid model membrane; Phosphatidylserine; Specific capacity

Indexed keywords

CONCENTRATION RANGES; HYDROPHOBIC REGIONS; LIPID MODEL; LOCAL DEFECTS; LOW CONCENTRATIONS; PHOSPHATIDYLSERINE; PRISTINE FULLERENES; SPECIFIC CAPACITIES; SPECIFIC CONDUCTIVITY; WATER MOLECULE;

CELL MEMBRANES; CYTOLOGY; ELECTRIC CONDUCTIVITY;

FULLERENES;

FULLERENE DERIVATIVE; PHOSPHATIDYLSERINE; PRISTINE FULLERENE C60; UNCLASSIFIED DRUG; WATER;

ARTICLE; ARTIFICIAL MEMBRANE; CELL MEMBRANE; CONDUCTANCE; ELECTROCHEMISTRY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID BILAYER;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DIFFUSION; ELECTRIC CONDUCTIVITY; FULLERENES; HELA CELLS; HUMANS; LIPID BILAYERS; MEMBRANE FLUIDITY; SOLUBILITY; WATER;

EID: 84862290772     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1404     Document Type: Article

References (30)

1. Y. Gogotsi (ed.), Nanomaterials Handbook, CRC Press, Taylor & Francis Group (2006).
2. R. Bakry, R. M. Vallant, M. Najam-Ul-Haq, M. Rainer, Z. Szabo, C. W. Huck, and G. K. Bonn, Medicinal applications of fullerenes. Int. J. Nanomed. 2, 639 (2007).
3. F. Cataldo and T. Da Ros, Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes. series: Carbon materials: Chemistry and physics. Vol. 1. - Springer, Netherlands (2008).
4. S. Kato, H. Aoshima, Y. Saitoh, and N. Miwa, Defensive effects of fullerene C60 dissolved in squalane against the 2, 4-nonadienal-induced cell injury in human skin keratinocytes HaCaT and wrinkle formation in 3D-human skin tissue model. J. Biomed. Nanotechnol. 6, 52 (2010).
5. G. Andrievsky, V. Klochkov, and L. Derevyanchenko, Is the C60 Fullerene Molecule Toxic?! Fullerenes, Nanotubes, Carbon Nanostruct. 13, 363 (2005).
6. S. V. Prylutska, O. P. Matyshevska, A. A. Golub, Y. I. Prylutskyy, G. P. Potebnya, U. Ritter, and P. Scharff, Study of Ñ60 fullerenes and Ñ60 -containing composites cytotoxicity in vitro. Mater. Sci. Eng. C 27, 1121 (2007).
7. H. J. Johnston, G. R. Hutchison, F. M. Christensen, K. Aschberger, and V. Stone, The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol. Sci. 114, 162 (2010).
8. S. V. Prylutska, I. I. Grynyuk, O. P. Matyshevska, Y. I. Prylutskyy, U. Ritter, and P. Scharff, Anti-oxidant properties of C60 fullerenes in vitro. Fullerenes, Nanotubes, Carbon Nanostruct. 16, 698 (2008).
9. S. Murugesan, S. A. Mousa, L. J. O'Connor, D. W. Lincoln, and R. J. Linhardt, Carbon inhibits vascular endothelial growth factorand fibroblast growth factor-promoted angiogenesis. FEBS Lett. 581, 1157 (2007).
10. D. Drobne, V. Kralj-Iglic, Lipid membranes as tools in nanotoxicity studies. Adv. Planar Lipid Bilayers and Liposomes 10, 121 (2009).
11. O. L. Katsamenis, N. Bouropoulos, and D. G. Fatouros, Interaction of fullerenes C60 with large unilamellar vesicles. J. Biomed. Nanotechnol. 5, 416 (2009).
12. T. A. Spurlin and A. A. Gewirth, Effect of C60 on solid supported lipid bilayers. Nano Lett. 7, 531 (2007).
13. P. R. Leroueil, S. Y. Hong, A. Mecke, J. R. Baker, B. G. Orr, and M. M. B. Holl, Nanoparticle interaction with biological membranes, Does nanotechnology present a janus face?. Acc. Chem. Res. 40, 335 (2007).
14. L. Li, H. Davande, D. Bedrov, and G. D. Smith, A molecular dynamics simulation study of C60 fullerenes inside a dimyristoylphosphatidylcholine lipid bilayer. J. Phys. Chem. B 111, 4067 (2007).
15. D. Bedrov, G. D. Smith, H. Davande, and L. Li, Passive transport of C60 fullerenes through a lipid membrane: A molecular dynamics simulation study. J. Phys. Chem. B 112, 2078 (2008).
16. J. Wong-Ekkabut, S. Baoukina, W. Triampo, I. M. Tang, D. P. Tieleman, and L. Monticelli, Computer simulation study of fullerene translocation through lipid membranes. Nat. Nanotechnol. 3, 363 (2008).
17. R. S. G. D'Rozario, C. L. Wee, E. J. Wallace, and M. S. P. Sansom, The interaction of C60 and its derivatives with a lipid bilayer via molecular dynamics simulations. Nanotechnol. 20, 115102 (2009).
18. L. Monticelli, E. Salonen, P. C. Ke, and I. Vattulainen, Effects of carbon nanoparticles on lipid membranes: A molecular simulation perspective. Soft Matter 5, 4433 (2009).
19. P. Scharff, K. Risch, L. Carta-Abelmann, I. M. Dmytruk, M. M. Bilyi, O. A. Golub, A. V. Khavryuchenko, E. V. Buzaneva, V. L. Aksenov, M. V. Avdeev, Y. I. Prylutskyy, and S. S. Durov, Structure of C60 fullerene in water: spectroscopic data. Carbon 42, 1203 (2004).
20. Y. I. Prylutski, S. S. Durov, V. N. Yashchuk, T. Y. Ogul'chansky, V. E. Pogorelov, Y. A. Astashkin, E. V. Buzaneva, Y. D. Kirghizov, G. V. Andrievsky, and P. Scharff, Theoretical predictions and experimental studies of self-organization C60 nanoparticles in water solution and on the support. Eur. Phys. J. D 9, 341 (1999).
21. L. Bulavin, I. Adamenko, Yu. Prylutskyy, S. Durov, A. Graja, A. Bogucki, and P. Scharff, Structure of fullerene C60 in aqueous solution. Phys. Chem. Chem. Phys. 2, 1627 (2000).
22. S. V. Prylutska, A. P. Burlaka, P. P. Klymenko, I. I. Grynyuk, Y. I. Prylutskyy, Ch. Schütze, and U. Ritter, Using water-soluble C60 fullerenes in anticancer therapy. Cancer Nanotechnol. DOI 10.1007/s12645-011-0020 (2011)
23. P. Mueller, D. O. Rudin, H. T. Tien, and W. C. Wescott, Methods for the formation of single bimolecylar lipid membranes in aqueous solution. Nature 194, 976 (1962).
24. A. M. Omelchenko, B. A. Bovykin, and T. V. Sytnik, The measurement of bilayer lipid membrane capacitance by non-steady cyclic current-voltage characteristics. Mol. Genet. Biophys. 15, 17 (1990).
25. I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271 (1991).
26. R. Bilyy, A. Podhorodecki, M. Nyk, R. Stoika, A. Zaichenko, J. Misiewicz, and W. Strek, Utilization of GaN: Eu3+ nanocrystals for the detection of programmed cell death. Physica E 40, 2096 (2008).
27. D. Dubois, G. Moninot, W. Kutner, M. T. Jones, and K. M. Kadish, Electroreduction of Buckminsterfullerene, C60, in Aprotic Solvents: Solvent, Supporting Electrolyte, and Temperature Effects. J. Phys. Chem. 96, 7137 (1992).
28. R. A. Chaurio, C. Janko, L. E. Munoz, B. Frey, M. Herrmann and U. S. Gaipl, Phospholipids: Key players in apoptosis and immune regulation. Molecules 14, 4892 (2009).
29. V. A. Fadok, D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207 (1992).
30. S. V. Prylutska, A. P. Burlaka, and Y. I. Prylutskyy, Application of unmodified C60 fullerenes as anticancer agents in the therapy of malignant tumors. Patent of Ukraine for an invention, N a2011 04882, (2011).